SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000891554-02-001567
Filing Date
2002-03-27
Accepted
2002-03-27 00:00:00
Documents
2
Period of Report
2002-05-15

Document Format Files

Seq Description Document Type Size
1 d50045_def14a.htm DEF 14A 186178
4 GRAPHIC g50045_chart.gif GRAPHIC 10282
  Complete submission text file 0000891554-02-001567.txt   198014
Mailing Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244
Business Address 2190 PKWY LAKE DR BIRMINGHAM AL 35244 2054444600
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-23186 | Film No.: 02589098
SIC: 2836 Biological Products, (No Diagnostic Substances)